Shenzhen Xianjian Xinkang Medical Electronics Secures Tens of Millions RMB in Series A Funding from Chuangdongfang Investment to Advance Cardiovascular Implantable Device Innovation

Intelligent Finance APP learned that, according to the "CDF-Capital Investment" WeChat Official Account, recently, CDF-Capital completed a multi-million yuan Series A investment in Shenzhen Lifetech Cardio Medical Electronics Co., Ltd. (hereinafter referred to as Lifetech Cardio), a cardiovascular medical device manufacturer. This round of investment will be used to expand research and development, construct production facilities, replenish operating funds, and acquire equity.

According to publicly available information, Lifetech Cardio (Xianjian Xinkang) was established in November 2017. It focuses on the research and development, manufacturing, and sales of innovative cardiovascular active implantable medical devices. Its first independently developed Class III innovative medical device, the 8301 temporary pacemaker, is the first domestically produced temporary pacemaker approved for marketing in China, filling a gap in the domestic market.